Tech Company Financing Transactions
Oligomerix Funding Round
Oligomerix closed a $400 thousand funding round on 4/15/2015. Investors included private investors.
Transaction Overview
Company Name
Announced On
4/15/2015
Transaction Type
Venture Equity
Amount
$400,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1300 Morris Park Ave. 1211
Bronx, NY 10461
USA
Bronx, NY 10461
USA
Phone
Website
Email Address
Overview
OLIGOMERIX Inc., is a biopharmaceutical company focused on developing novel drug discovery targets and therapeutics for Alzheimer's disease and other neurodegenerative disorders. Founded in 2006, OLIGOMERIX has filed patents on tau protein oligomers (soluble aggregates) for drug and biomarker discovery.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
James Moe
Chief Financial Officer
Robert Foerster
Chief Medical Officer
William Erhardt
Chief Scientific Officer
Eliot Davidowitz
VP - Marketing
Jack Pasini
Browse more venture capital transactions:
Prev: 4/15/2015: RetailNext venture capital transaction
Next: 4/15/2015: Arcadia Healthcare Solutions venture capital transaction
Share this article
Where The Data Comes From
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs